Rituximab in neurological disease: principles, evidence and practice
Sign Up to like & getrecommendations! Published in 2018 at "Practical Neurology"
DOI: 10.1136/practneurol-2018-001899
Abstract: Rituximab is a widely used B-cell-depleting monoclonal antibody. It is unlicensed for use in neurological disorders and there are no treatment guidelines. However, as a rapidly acting, targeted therapy with growing evidence of efficacy and… read more here.
Keywords: disease principles; rituximab neurological; evidence practice; evidence ... See more keywords